表面工程精密纳米系统用于针对性治疗亨廷顿病:对最近的进展进行了回顾
Jingze Zhang1, Lili Nie2, Jingru Ma3
1Department of Neurosurgery, The Second Hospital of Jilin University, Changchun, 130000, People's Republic of China.
International journal of nanomedicine
|February 27, 2026
概括
表面工程纳米系统显示出治疗亨廷顿病的前景,通过精确地通过血脑屏障传递疗法. 这些先进的纳米粒子系统提供了有针对性的治疗,提高了疗效,减少了这种渐进的神经疾病的副作用.
科学领域:
- 神经科学是一个神经科学.
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 亨廷顿病是一种进展性神经系统疾病,没有治疗方法,其特点是运动,认知和精神症状.
- 目前对亨廷顿病的诊断工具和治疗方法在阻止或逆转疾病进展的能力上是有限的.
研究的目的:
- 审查最近在表面工程纳米系统的进展,用于亨廷顿病的治疗.
- 探索纳米系统在克服血脑屏障和改善亨廷顿病药物输送等挑战方面的潜力.
主要方法:
- 关于各种纳米系统 (脂质体,树脂体,聚合物纳米粒子,固体脂质纳米粒子) 的文献综述.
- 分析纳米系统在向和调节疾病途径方面的能力.
- 对跨越血脑屏障和在亨廷顿病模型中的治疗交付研究的审查.
主要成果:
- 纳米系统展示了精确向受影响的大脑区域输送药物的潜力,提高了疗效,并最大限度地减少了系统性副作用.
- 最近的发展解决了克服血脑屏障和改善治疗交付机制的挑战.
- 对亨廷顿病的基于纳米粒子的诊断也在出现.
结论:
- 表面工程纳米系统代表了亨廷顿病的变革性治疗平台.
- 尽管在安全评估和监管批准方面存在挑战,但纳米系统对未来的亨廷顿病治疗有很大的前景.
- 通过纳米系统进行有针对性的输送,为亨廷顿病改善治疗结果提供了一条途径.
更多相关视频
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
16.5K
07:00Targeting of Deep Brain Structures with Microinjections for Delivery of Drugs, Viral Vectors, or Cell Transplants
Published on: December 1, 2010
13.3K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Site-Targeted Drug Delivery Systems: Polymeric Carriers
59
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59
